Cardiovascular health assessment in routine cancer follow-up in community settings : survivor risk awareness and perspectives
© 2024. The Author(s)..
BACKGROUND: Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspectives in community settings. We aimed to (1) Assess survivor CVH profiles, (2) compare self-reported and EHR-based categorization of CVH factors, and (3) describe perceptions regarding addressing CVH during oncology encounters.
METHODS: This cross-sectional analysis utilized data from an ongoing NCI Community Oncology Research Program trial of an EHR heart health tool for cancer survivors (WF-1804CD). Survivors presenting for routine care after potentially curative treatment recruited from 8 oncology practices completed a pre-visit survey, including American Heart Association Simple 7 CVH factors (classified as ideal, intermediate, or poor). Medical record abstraction ascertained CVD risk factors and cancer characteristics. Likert-type questions assessed desired discussion during oncology care.
RESULTS: Of 502 enrolled survivors (95.6% female; mean time since diagnosis = 4.2 years), most had breast cancer (79.7%). Many survivors had common cardiovascular comorbidities, including high cholesterol (48.3%), hypertension or high BP (47.8%) obesity (33.1%), and diabetes (20.5%); 30.5% of survivors received high cardiotoxicity potential cancer treatment. Less than half had ideal/non-missing levels for physical activity (48.0%), BMI (18.9%), cholesterol (17.9%), blood pressure (14.1%), healthy diet (11.0%), and glucose/ HbA1c (6.0%). While > 50% of survivors had concordant EHR-self-report categorization for smoking, BMI, and blood pressure; cholesterol, glucose, and A1C were unknown by survivors and/or missing in the EHR for most. Most survivors agreed oncology providers should talk about heart health (78.9%).
CONCLUSIONS: Tools to promote CVH discussion can fill gaps in CVH knowledge and are likely to be well-received by survivors in community settings.
TRIAL REGISTRATION: NCT03935282, Registered 10/01/2020.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
BMC cancer - 24(2024), 1 vom: 31. Jan., Seite 158 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weaver, Kathryn E [VerfasserIn] |
---|
Links: |
---|
Themen: |
97C5T2UQ7J |
---|
Anmerkungen: |
Date Completed 09.02.2024 Date Revised 10.02.2024 published: Electronic ClinicalTrials.gov: NCT03935282 Citation Status MEDLINE |
---|
doi: |
10.1186/s12885-024-11912-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367865351 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367865351 | ||
003 | DE-627 | ||
005 | 20240210233210.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240201s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12885-024-11912-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1287.xml |
035 | |a (DE-627)NLM367865351 | ||
035 | |a (NLM)38297229 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Weaver, Kathryn E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiovascular health assessment in routine cancer follow-up in community settings |b survivor risk awareness and perspectives |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.02.2024 | ||
500 | |a Date Revised 10.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a ClinicalTrials.gov: NCT03935282 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Guidelines recommend cardiovascular risk assessment and counseling for cancer survivors. For effective implementation, it is critical to understand survivor cardiovascular health (CVH) profiles and perspectives in community settings. We aimed to (1) Assess survivor CVH profiles, (2) compare self-reported and EHR-based categorization of CVH factors, and (3) describe perceptions regarding addressing CVH during oncology encounters | ||
520 | |a METHODS: This cross-sectional analysis utilized data from an ongoing NCI Community Oncology Research Program trial of an EHR heart health tool for cancer survivors (WF-1804CD). Survivors presenting for routine care after potentially curative treatment recruited from 8 oncology practices completed a pre-visit survey, including American Heart Association Simple 7 CVH factors (classified as ideal, intermediate, or poor). Medical record abstraction ascertained CVD risk factors and cancer characteristics. Likert-type questions assessed desired discussion during oncology care | ||
520 | |a RESULTS: Of 502 enrolled survivors (95.6% female; mean time since diagnosis = 4.2 years), most had breast cancer (79.7%). Many survivors had common cardiovascular comorbidities, including high cholesterol (48.3%), hypertension or high BP (47.8%) obesity (33.1%), and diabetes (20.5%); 30.5% of survivors received high cardiotoxicity potential cancer treatment. Less than half had ideal/non-missing levels for physical activity (48.0%), BMI (18.9%), cholesterol (17.9%), blood pressure (14.1%), healthy diet (11.0%), and glucose/ HbA1c (6.0%). While > 50% of survivors had concordant EHR-self-report categorization for smoking, BMI, and blood pressure; cholesterol, glucose, and A1C were unknown by survivors and/or missing in the EHR for most. Most survivors agreed oncology providers should talk about heart health (78.9%) | ||
520 | |a CONCLUSIONS: Tools to promote CVH discussion can fill gaps in CVH knowledge and are likely to be well-received by survivors in community settings | ||
520 | |a TRIAL REGISTRATION: NCT03935282, Registered 10/01/2020 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cancer survivorship | |
650 | 4 | |a Care delivery model | |
650 | 4 | |a Electronic Health Records | |
650 | 4 | |a Lifestyle risk factors | |
650 | 7 | |a Cholesterol |2 NLM | |
650 | 7 | |a 97C5T2UQ7J |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
700 | 1 | |a Dressler, Emily V |e verfasserin |4 aut | |
700 | 1 | |a Smith, Sydney |e verfasserin |4 aut | |
700 | 1 | |a Nightingale, Chandylen L |e verfasserin |4 aut | |
700 | 1 | |a Klepin, Heidi D |e verfasserin |4 aut | |
700 | 1 | |a Lee, Simon Craddock |e verfasserin |4 aut | |
700 | 1 | |a Wells, Brian J |e verfasserin |4 aut | |
700 | 1 | |a Hundley, W Gregory |e verfasserin |4 aut | |
700 | 1 | |a DeMari, Joseph A |e verfasserin |4 aut | |
700 | 1 | |a Price, Sarah N |e verfasserin |4 aut | |
700 | 1 | |a Foraker, Randi E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC cancer |d 2001 |g 24(2024), 1 vom: 31. Jan., Seite 158 |w (DE-627)NLM111431948 |x 1471-2407 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g day:31 |g month:01 |g pages:158 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12885-024-11912-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 1 |b 31 |c 01 |h 158 |